Literature DB >> 2447017

Determinants of immunogenicity and mechanisms of protection by virulent and mutant Vibrio cholerae O1 in rabbits.

N F Pierce1, W C Cray, J B Kaper, J J Mekalanos.   

Abstract

The colonizing capacities of 16 Vibrio cholerae strains, including nine genetically and/or phenotypically defined parent-mutant pairs, were determined in unobstructed adult rabbit small bowel. There were marked interstrain differences in colonizing capacity, which was enhanced by bacterial motility and the production of cholera holotoxin but was unrelated to production of cholera toxin B-subunit or hemolysin or to bacterial serotype or biotype. The role of colonizing capacity and other bacterial features in determining the immunizing efficiency of live V. cholerae was studied by determining the efficiency with which graded inocula of each strain immunized against attempted recolonization of the ileum or induction of choleralike diarrhea by the RITARD (removable intestinal tie-adult rabbit diarrhea) challenge technique using standard inocula of virulent V. cholerae. Mucosal colonizing capacity was the only quantitative predictor of bacterial immunizing capacity; none of the other bacterial features cited above influenced bacterial immunogenicity against either type of challenge, except as they affected colonizing capacity. Live V. cholerae immunized much more efficiently than Formalin-killed bacteria; the former caused marked protection after a single inoculum of 10(2) CFU, whereas the latter gave only partial protection after three inoculations of 10(11) killed organisms. Protection induced by live bacteria was due largely to resistance to colonization and included marked inhibition of bacterial growth within the bowel lumen. These findings strongly suggest that an optimally efficient oral cholera vaccine would be composed of avirulent live V. cholerae selected for their capacity to colonize the small-bowel mucosa.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2447017      PMCID: PMC259248          DOI: 10.1128/iai.56.1.142-148.1988

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  Selection and characteristics of a Vibrio cholerae mutant lacking the A (ADP-ribosylating) portion of the cholera enterotoxin.

Authors:  T Honda; R A Finkelstein
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205

2.  Synergistic protective effect in rabbits of immunization with Vibrio cholerae lipopolysaccharide and toxin/toxoid.

Authors:  A M Svennerholm; J Holmgren
Journal:  Infect Immun       Date:  1976-03       Impact factor: 3.441

3.  Suppression of growth of Vibrio cholerae in the intestine of immunized mice.

Authors:  J Knop; J E Bellamy
Journal:  Med Microbiol Immunol       Date:  1976-06-01       Impact factor: 3.402

4.  Response of man to infection with Vibrio cholerae. II. Protection from illness afforded by previous disease and vaccine.

Authors:  R A Cash; S I Music; J P Libonati; J P Craig; N F Pierce; R B Hornick
Journal:  J Infect Dis       Date:  1974-10       Impact factor: 5.226

5.  Protection against enteric bacterial infection by secretory IgA antibodies.

Authors:  E S Fubara; R Freter
Journal:  J Immunol       Date:  1973-08       Impact factor: 5.422

6.  Protection against experimental cholera by antitoxin.

Authors:  N F Pierce; E A Kaniecki; R S Northrup
Journal:  J Infect Dis       Date:  1972-12       Impact factor: 5.226

7.  Motility as a virulence factor for Vibrio cholerae.

Authors:  M N Guentzel; L J Berry
Journal:  Infect Immun       Date:  1975-05       Impact factor: 3.441

8.  Differences in the response of rabbit small intestine to heat-labile and heat-stable enterotoxins of Escherichia coli.

Authors:  D G Evans; D J Evans; N F Pierce
Journal:  Infect Immun       Date:  1973-06       Impact factor: 3.441

9.  Simple adult rabbit model for Vibrio cholerae and enterotoxigenic Escherichia coli diarrhea.

Authors:  W M Spira; R B Sack; J L Froehlich
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

10.  Isolation of enterotoxin structural gene deletion mutations in Vibrio cholerae induced by two mutagenic vibriophages.

Authors:  J J Mekalanos; S L Moseley; J R Murphy; S Falkow
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

View more
  14 in total

1.  Difference between bacterial and food antigens in mucosal immunogenicity.

Authors:  A E Wold; U I Dahlgren; L A Hanson; I Mattsby-Baltzer; T Midvetdt
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

2.  Synthesis, characterization, and some immunological properties of conjugates composed of the detoxified lipopolysaccharide of Vibrio cholerae O1 serotype Inaba bound to cholera toxin.

Authors:  R K Gupta; S C Szu; R A Finkelstein; J B Robbins
Journal:  Infect Immun       Date:  1992-08       Impact factor: 3.441

3.  Vibrio cholerae O1 adherence to villi and lymphoid follicle epithelium: in vitro model using formalin-treated human small intestine and correlation between adherence and cell-associated hemagglutinin levels.

Authors:  T Yamamoto; T Kamano; M Uchimura; M Iwanaga; T Yokota
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

4.  Protective immunity against Clostridium difficile toxin A induced by oral immunization with a live, attenuated Vibrio cholerae vector strain.

Authors:  E T Ryan; J R Butterton; R N Smith; P A Carroll; T I Crean; S B Calderwood
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

5.  The Live Attenuated Cholera Vaccine CVD 103-HgR Primes Responses to the Toxin-Coregulated Pilus Antigen TcpA in Subjects Challenged with Wild-Type Vibrio cholerae.

Authors:  Leslie M Mayo-Smith; Jakub K Simon; Wilbur H Chen; Douglas Haney; Michael Lock; Caroline E Lyon; Stephen B Calderwood; Beth D Kirkpatrick; Mitchell Cohen; Myron M Levine; Marc Gurwith; Jason B Harris
Journal:  Clin Vaccine Immunol       Date:  2017-01-05

6.  Nucleotide sequence encoding the mannose-fucose-resistant hemagglutinin of Vibrio cholerae O1 and construction of a mutant.

Authors:  V L Franzon; A Barker; P A Manning
Journal:  Infect Immun       Date:  1993-07       Impact factor: 3.441

Review 7.  Vibrio cholerae: lessons for mucosal vaccine design.

Authors:  Anne L Bishop; Andrew Camilli
Journal:  Expert Rev Vaccines       Date:  2011-01       Impact factor: 5.217

8.  Salmonella typhimurium mutants lacking flagella or motility remain virulent in BALB/c mice.

Authors:  H A Lockman; R Curtiss
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

9.  Efficacy of enteric-coated protease in preventing attachment of enterotoxigenic Escherichia coli and diarrheal disease in the RITARD model.

Authors:  T L Mynott; D S Chandler; R K Luke
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

10.  Heterologous antigen expression in Vibrio cholerae vector strains.

Authors:  J R Butterton; D T Beattie; C L Gardel; P A Carroll; T Hyman; K P Killeen; J J Mekalanos; S B Calderwood
Journal:  Infect Immun       Date:  1995-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.